Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 2 clinical trial registry record with no reported results; it describes a planned study of tucatinib combination therapy in heavily pretreated HER2+ breast cancer.
This is a Phase 1 study registration with no posted results; it is designed to establish safety and maximum tolerated dose in a small population, representing early-stage clinical evaluation.
This is a Phase I/II trial registration with no posted results; it is actively enrolling to establish safety, tolerability, and preliminary efficacy in a novel radiopharmaceutical combination.
This is a Phase 3 RCT registration with no posted results; the study is actively recruiting and outcome data are not yet available for clinical interpretation.
This is an active Phase 3 trial registration with no results reported; it describes a planned comparison but cannot yet support clinical evidence or practice guidance.